Assembly Biosciences, Inc. Gain (Loss) on Disposition of Assets
Assembly Biosciences, Inc. (ASMB) reported Gain (Loss) on Disposition of Assets of -$1.63 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2021-11-04
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2021-09-30 was $0.00.
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2021-06-30 was -$14.00K.
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2021-03-31 was -$1.61M.
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for the quarter ending 2020-12-31 was -$9.00K.
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2020 was -$9.00K.
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2019 was -$102.00K.
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2018 was $0.00.
- Assembly Biosciences, Inc. gain (loss) on disposition of assets for fiscal 2017 was $0.00.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$14.00K derived: sum of 2 quarters · filed 2021-11-04 | -$1.63M 10-Q · filed 2021-11-04 | -$1.63M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$1.63M 10-Q · filed 2021-08-05 | -$1.63M derived: sum of 3 quarters · filed 2021-08-05 | -$1.63M derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-03-31 | -$1.61M 10-Q · filed 2021-05-06 | -$1.62M derived: sum of 2 quarters · filed 2021-05-06 | -$1.62M derived: sum of 3 quarters · filed 2021-11-04 | -$1.62M derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$9.00K derived: sum of 2 quarters · filed 2021-11-04 | -$9.00K derived: sum of 3 quarters · filed 2021-11-04 | -$9.00K 10-K · filed 2021-02-25 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $0.00 derived: sum of 2 quarters · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $0.00 derived: sum of 4 quarters · filed 2021-11-04 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | $0.00 derived: sum of 3 quarters · filed 2021-08-05 | $0.00 derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | $0.00 derived: sum of 2 quarters · filed 2021-05-06 | $0.00 derived: sum of 3 quarters · filed 2021-05-06 | $0.00 derived: sum of 4 quarters · filed 2021-05-06 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | -$102.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | -$102.00K 10-Q · filed 2020-11-05 | -$102.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$102.00K 10-Q · filed 2020-08-05 | -$102.00K derived: sum of 3 quarters · filed 2021-02-25 | -$102.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$102.00K 10-Q · filed 2020-05-08 | -$102.00K derived: sum of 2 quarters · filed 2021-02-25 | -$102.00K derived: sum of 3 quarters · filed 2021-02-25 | -$102.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $0.00 derived: sum of 2 quarters · filed 2019-11-07 | $0.00 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |